Diagnostic Discovery Research

Specificity that scales

Customizable antibody discovery workflows engineered for high affinity, sensitivity and exquisite specificity to meet the most discriminating diagnostic challenges.

Every diagnostic matters. Every result counts.

In diagnostics, accuracy is everything. MindWalk unites advanced lab rigor with scalable development to deliver antibodies that combine specificity, sensitivity, and reproducibility. With a validated discovery platform and rapid screening formats, our diagnostic antibody discovery workflow supports researchers in confidently advancing from discovery to commercialization.

500+ antibody diagnostic programs

Your extended team

Customized strategies for diagnostic antibody discovery. Decades of client retention built on scientific rigor and trusted collaboration.

>98% discovery success rate

with leading B cell technology

Diagnostic performance

From standard to complex programs, our antibodies are characterized by reliable sensitivity, specificity, and cross-platform accuracy.

Specificity


Target the most difficult-to-distinguish markers

Sensitivity


Detecting the hardest-to-find low abundance targets with precision

Reproducibility


Consistent performance across assays with minimal batch-to-batch variation

Stability


Durability and performance that withstand demanding workflows

Comprehensive expertise for advanced diagnostic solutions


Advanced diagnostic lab research:
Our antibody discovery platforms span the full journey—from target identification through protein production, with properties of exquisite specificity, low background, and high sensitivity.


Integrated LensAI™ support:
Customized intelligence built for you, ready when you need it, revealing insights that help shape superior, more refined clones.


Flexible protein production:
Rapid high-yield, consistent expression that scales as programs progress.

Where our research makes a broad impact

Oncology  +  Infectious Disease  +  Neurodegeneration  +  Metabolic Disease  +  Rare Disease  +  Inflammation  +  Market Kits

Diagnostics discovery across complex targets

Antibody discovery + development


Wide-range of flexible applications

Target

  • Target Analysis: Experience-based Antigen Design
  • Tool Generation: Custom Antigen Production, Assay Development

Discovery

  • Immunization: Standard, Rapid, Custom
  • Hit Generation & Candidate Selection: B cell Discovery, Hybridoma Discovery

Lead

  • Lead Characterization: Target Interaction Analysis
  • LensAI HYFT Prime™: Binding Affinity Optimization, Target Specificity and Selectivity
  • Target- and Application-specific Screening
  • Protein Production: Recombinant Protein Expression in CHO, HEK293, E.coli

Stable Production Cell Line

Functional Selection

  • Epitope Mapping
  • Affinity
  • Specificity
  • Competing/Non-competing
  • Pairing Identification
  • Application Relevant Screening

Species Diversity

+ Rabbit
+ Rodent

Superior Technology

+ B cell Select®
+ Hybridoma

Format Options

  • Full-length IgG
  • Custom Formats

Trusted by 19 of the top 20 pharma companies, next-gen biotechs, and top research institutions.

Trusted State graphic point, 19 form 20

Stronger starts.
#1 ranking lab1

1. ROOTS 2022: Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035; p.118

Protein production

Leading diagnostics developers trust our high-purity, reproducible proteins, driving long-standing client retention.

Start your diagnostic program today

Connect with scientists who understand diagnostics from discovery through commercialization

Case Studies

See validated insights that redefine workflows and optimize discovery success.

Scientific Posters

Discover how MindWalk powers smarter, faster paths from concept to clinic.

Blogs

Explore latest ideas reshaping the future of discovery.

Four ways to access MindWalk

We build it

Customizable offerings in biologics discovery—from target analysis to optimized leads.

You build it

Access to state-of-the-art LensAI SaaS Platform.

The Vault

Smarter starts: a portfolio of partner-ready assets.

Partnership

We are proud to partner with the best in pharma, biotech and academia organizations. Join us in creating future of human health.